Abstract | INTRODUCTION: PATIENTS AND METHODS: Twenty-three patients with high-grade glioma, who were initially examined with 11C-methionine (MET) and 18F-fluorodeoxyglucose (FDG) PET, were retrospectively enrolled. MET and FDG PET images were coregistered to each other and quantitative uptake of MET or FDG was assessed using tumor-to-normal uptake ratio of the cortex (TNR). TNRs for MET and FDG PET were compared between the two groups classified by MGMT promoter methylation status. RESULTS: Maximum TNR(FDG) of the MGMT methylated group was significantly higher than that of the MGMT unmethylated group (1.80±0.90 vs. 1.29±0.19; P=0.02). The MGMT methylated group also showed a trend for increased mean TNRFDG compared with the unmethylated group (0.85±0.21 vs. 0.72±0.11; P=0.10). There was no significant difference in TNR(MET) between the groups. In subgroup analyses with WHO grade 3 and 4, a trend for higher maximum TNR(FDG) was found in the MGMT methylated group compared with the unmethylated group. CONCLUSION: The MGMT methylated group showed higher glucose metabolism compared with the unmethylated group, whereas MET uptake did not show a significant difference. This suggests that MGMT methylation in high-grade gliomas could affect the tumor glucose metabolism. Thus, MGMT methylation status can cause a discrepancy in the prognostic prediction of high-grade gliomas by FDG PET, especially in patients scheduled for DNA alkylating chemotherapeutics.
|
Authors | Hongyoon Choi, Ji-In Bang, Gi Jeong Cheon, Yong Hwy Kim, Chul-Kee Park, Sung-Hye Park, Keon Wook Kang, June-Key Chung, Euishin E Kim, Dong Soo Lee |
Journal | Nuclear medicine communications
(Nucl Med Commun)
Vol. 36
Issue 3
Pg. 211-8
(Mar 2015)
ISSN: 1473-5628 [Electronic] England |
PMID | 25340951
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fluorodeoxyglucose F18
- carbon-11 methionine
- Methionine
- O(6)-Methylguanine-DNA Methyltransferase
|
Topics |
- Adolescent
- Adult
- Aged
- Child
- DNA Methylation
- Female
- Fluorodeoxyglucose F18
- Glioma
(diagnostic imaging, enzymology, genetics, pathology)
- Humans
- Male
- Methionine
- Middle Aged
- Neoplasm Grading
- O(6)-Methylguanine-DNA Methyltransferase
(genetics)
- Positron-Emission Tomography
- Prognosis
- Promoter Regions, Genetic
(genetics)
- Retrospective Studies
- Young Adult
|